Cardioconsult s.r.o.

At Cardioconsult s.r.o. in Stare Mesto, the clinical trial portfolio focuses on cardiovascular diseases, with studies centered on major conditions such as atrial fibrillation and atherosclerotic cardiovascular disease. The research is aimed at improving prevention and treatment strategies for serious heart-related events.

• Evaluating a new approach to preventing cardioembolic events in people with atrial fibrillation
• Studying treatment options for atherosclerotic cardiovascular disease alongside chronic kidney disease and systemic inflammation

These trials reflect a strong interest in testing therapies that may reduce the risk of stroke, embolic complications, and other major cardiovascular outcomes.

The Kardiologicka ambulancia at this health care site is contributing to research that compares emerging therapies with established care in cardiovascular disease. The studies are designed to assess whether new treatments can better protect patients from serious events such as stroke and major adverse cardiovascular outcomes.

• Comparing a novel anticoagulation strategy with standard therapy for atrial fibrillation
• Testing whether a targeted anti-inflammatory treatment can lower cardiovascular risk in patients with ASCVD and CKD

Overall, the research at Cardioconsult s.r.o. is focused on advancing practical options for patients with complex heart and blood vessel conditions.